Latest App Notes & Case Studies
![Genotoxic App Note Preview](https://assets.technologynetworks.com/production/dynamic/images/content/374246/confidence-in-compliance-genotoxic-impurity-analysis-374246-640x360.jpg?cb=12334475)
App Note / Case Study
Confidence in Compliance: Genotoxic Impurity Analysis
Stringent safety requirements associated with the analyses of carcinogenic and mutagenic impurities can present significant challenges. Methods must achieve a high level of sensitivity and selectivity while maintaining sufficient sample throughput.
![Protein Expression](https://assets.technologynetworks.com/production/dynamic/images/content/374062/the-new-gold-standard-for-gene-therapy-protein-expression-potency-measurements-374062-640x360.jpg?cb=12327231)
App Note / Case Study
The New Gold Standard for Gene Therapy Protein Expression Potency Measurements
A major challenge preventing transformative gene therapies from reaching patients is the lack of fit-for purpose potency assays, which are some of the most important assays in an analytical package but are often the most complex and high-risk.
![Successful SPR Assays](https://assets.technologynetworks.com/production/dynamic/images/content/373637/determining-real-time-kinetics-and-affinity-373637-640x360.jpg?cb=12361687)
App Note / Case Study
Determining Real-Time Kinetics and Affinity
This compendium serves as a user-friendly reference for assay design on both bio-layer interferometry (BLI) and surface plasmon resonance (SPR) systems.
![Oligos with Confidence](https://assets.technologynetworks.com/production/dynamic/images/content/373633/characterize-your-oligos-with-confidence-373633-640x360.jpg?cb=12466627)
App Note / Case Study
Characterize Your Oligos With Confidence
Custom oligo synthesis can result in the formation of impurities. Hence, final products must be characterized to ensure they meet quality assurance and control standards.
![Precision Oligo Sequencing](https://assets.technologynetworks.com/production/dynamic/images/content/373632/a-simplified-method-for-precision-oligo-sequencing-373632-640x360.jpg?cb=12454024)
App Note / Case Study
A Simplified Method for Precise Oligo Sequencing
LC/MS methods can be used to analyze a wide range of oligo samples. However, ion-pairing reagents can interfere with analyses and present challenges in multi-use systems.
![Antigen](https://assets.technologynetworks.com/production/dynamic/images/content/373456/fast-track-antigen-specific-b-and-t-cell-discovery-373456-640x360.jpg?cb=12293955)
App Note / Case Study
Fast Track Antigen-Specific B- and T-Cell Discovery
This application note demonstrates how Single Cell Immune Profiling and Barcode Enabled Antigen Mapping (BEAM) can be used to profile thousands of hPBMCs from a single donor.
![CAR T: A Promising Cell Therapy for Cancer Treatment content piece image](https://assets.technologynetworks.com/production/dynamic/images/content/372559/car-t-a-promising-cell-therapy-for-cancer-treatment-372559-640x360.jpg?cb=12276826)
App Note / Case Study
CAR T: A Promising Cell Therapy for Cancer Treatment
CAR-T cell therapy has emerged as one of the most promising novel treatments in the fight against cancer.
![Transitioning From RUO to cGMP for Clinical Trials content piece image](https://assets.technologynetworks.com/production/dynamic/images/content/372155/transitioning-from-ruo-to-cgmp-for-clinical-trials-372155-640x360.jpg?cb=12246711)
App Note / Case Study
Transitioning From RUO to cGMP for Clinical Trials
Both RUO and cGMP compliance play important roles in the drug discovery pipeline. However, meeting regulatory demands can be a challenge when accelerating new drugs to the clinic.
![Streamline Your Metabolite Identification and Clearance Analyses content piece image](https://assets.technologynetworks.com/production/dynamic/images/content/371895/streamline-your-metabolite-identification-and-clearance-analyses-371895-640x360.jpg?cb=12472635)
App Note / Case Study
Streamline Your Metabolite Identification and Clearance Analyses
Discover an automated solution for the consolidation and ranking of your metabolite structures. Explore a workflow that utilizes both EAD and CID data for the most confident characterization and streamlined data acquisition.
Advertisement